Select Your Profession

Choose your profession to view pricing and course information tailored to you.

arrow_back Back to Course List
play_circle Video

From Onset to Outcome: Acute Kidney Injury Insights for Healthcare Professionals

Target Audience: Pharmacy Tech

star star star star star 4.5/5 based on 34 ratings
schedule 1.00 Contact Hours (0.10 CEUs)
category Disease State Management/Drug Therapy
local_activity Knowledge

Course Overview

Acute Kidney Injury (AKI) represents a complex clinical challenge, often demanding swift diagnosis, interdisciplinary collaboration, and judicious therapeutic intervention. The implications of AKI range from transient renal dysfunction to severe complications. The landscape of AKI management continues to evolve, and this continuing education program aims to provide healthcare providers with a holistic perspective on the latest developments in AKI. This monograph will discuss the pathophysiology of AKI, methods by which to detect and risk stratify AKI, and modalities for prevention and treatment.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Recall the pathophysiological mechanisms, causes, and diagnostic biomarkers of acute kidney injury (AKI)
  • Recall evidence-based therapeutic interventions for AKI
  • Describe the role of interdisciplinary collaboration in AKI management
  • Describe tools and techniques to effectively educate and guide patients regarding AKI

Faculty

Authors & Activity Planners
Liz Fredrickson, PharmD, BCPS
View Bio +
Liz Fredrickson is an Associate Professor of Pharmacy Practice and Pharmaceutical Sciences at the Northeast Ohio Medical University College of Pharmacy. She serves as the Director of Instructional Labs and is course director for the Basic Pharmaceutics Lab and Parenteral Products and Parenteral Products Lab courses.

I. Introduction

II. Diagnostic and Staging Criteria

III. Epidemiology

IV. Etiology and Risk Factors

1. Prerenal AKI
2. Intrarenal AKI
3. Postrenal AKI

V. Clinical Presentation and Diagnosis

1. Patient History
2. Physical Examination

VI. Preventing AKI

VII. Managing AKI

1. Assessing Volume Status and Hemodynamic Stability
2. Scrutinizing Medications
3. Renal Replacement Therapy

VIII. Interdisciplinary Collaboration

IX. Patient Education

X. The Role of the Pharmacists and Staff

XI. Key Takeaways

XII. Summary

From December 20, 2023 through December 20, 2026, participants must:

  1. Read the "learning objectives" and "author and planning team disclosures"
  2. Study the section entitled "educational activity"
  3. Complete the Course Test and Evaluation form. The Course Test will be graded automatically. Following successful completion of the Course Test with a score of 70% or higher, a statement of participation will be made available immediately. (No partial credit will be given.)

Credit for this course will be automatically uploaded to CPE Monitor®.

Faculty Planner Disclosure

The following individuals were involved in the development of this activity: Liz Fredrickson, PharmD, BCPS, and Pamela Sardo, PharmD, BS. Pamela Sardo was an employee of Rhythm Pharmaceuticals until March 2022 and has no conflicts of interest or relationships regarding the subject matter discussed. There are no financial relationships relevant to this activity to report or disclose by any of the individuals involved in the development of this activity.

Unlabeled Use Disclosure

The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.

Please ensure the device you plan to use meets these requirements:

  • Operating System: Windows 7, 8, 10, or 11 / Mac OS X 10.9 or later / iOS / Android
  • Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
  • A connection to the internet

Accreditation

In support of improving patient care, RxCE.com is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PTCB Recognition

RxCe.com, LLC, offers pharmacy technician continuing education courses for PTCB recertification. Pharmacy technician courses are indicated both in the Target Audience description and the ACPE UAN which will end with a "T".